Viracta Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viracta Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $77k | 74k | 1.04 |
| 2023-06-30 | $176k | 125k | 1.41 |
| 2023-03-31 | $199k | 125k | 1.59 |
| 2022-12-31 | $183k | 125k | 1.46 |
| 2022-09-30 | $406k | 95k | 4.27 |
| 2022-06-30 | $272k | 70k | 3.89 |
| 2022-03-31 | $333k | 70k | 4.76 |
| 2021-12-31 | $128k | 35k | 3.66 |
| 2021-09-30 | $401k | 50k | 8.02 |
| 2021-06-30 | $567k | 50k | 11.34 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management